PDCD1 and neoplasm: We applied mIHC and image-based flow cytometry, a novel and powerful technique that provides subcellular parameter information, to investigate the percentage of CD8+ T lymphoid cells expressing the T cell exhaustion marker PD-1 and the percentage of CD68+ tumor-associated macrophages (TAMs) expressing the checkpoint PD-L1 in PDAC.